These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J0725

  Injection, chorionic gonadotropin, per 1,000 usp units

• J0735

  Injection, clonidine hydrochloride, 1 mg

• J0736

  Injection, clindamycin phosphate, 300 mg

• J0737

  Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg

• J0738

  Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)

• J0739

  Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)

• J0740

  Injection, cidofovir, 375 mg

• J0741

  Injection, cabotegravir and rilpivirine, 2mg/3mg

• J0742

  Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg

• J0743

  Injection, cilastatin sodium; imipenem, per 250 mg

• J0744

  Injection, ciprofloxacin for intravenous infusion, 200 mg

• J0745

  Injection, codeine phosphate, per 30 mg

• J0750

  Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)

• J0751

  Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)

• J0752

  Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)

• J0759

  Injection, clevidipine butyrate, 1 mg

• J0760

  Injection, colchicine, per 1 mg

• J0770

  Injection, colistimethate sodium, up to 150 mg

• J0775

  Injection, collagenase, clostridium histolyticum, 0.01 mg

• J0780

  Injection, prochlorperazine, up to 10 mg

• J0791

  Injection, crizanlizumab-tmca, 5 mg

• J0795

  Injection, corticorelin ovine triflutate, 1 microgram

• J0799

  Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified

• J0800

  Injection, corticotropin, up to 40 units

• J0801

  Injection, corticotropin (acthar gel), up to 40 units

• J0802

  Injection, corticotropin (ani), up to 40 units

• J0833

  Injection, cosyntropin, not otherwise specified, 0.25 mg

• J0834

  Injection, cosyntropin, 0.25 mg

• J0840

  Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram

• J0841

  Injection, crotalidae immune f(ab')2 (equine), 120 mg

• J0850

  Injection, cytomegalovirus immune globulin intravenous (human), per vial

• J0870

  Injection, imetelstat, 1 mg

• J0872

  Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg

• J0873

  Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg

• J0874

  Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg

• J0875

  Injection, dalbavancin, 5 mg

• J0877

  Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg

• J0878

  Injection, daptomycin, 1 mg

• J0879

  Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)

• J0881

  Injection, darbepoetin alfa, 1 microgram (non-esrd use)

• J0882

  Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)

• J0883

  Injection, argatroban, 1 mg (for non-esrd use)

• J0884

  Injection, argatroban, 1 mg (for esrd on dialysis)

• J0885

  Injection, epoetin alfa, (for non-esrd use), 1000 units

• J0886

  Injection, epoetin alfa, 1000 units (for esrd on dialysis)

• J0887

  Injection, epoetin beta, 1 microgram, (for esrd on dialysis)

• J0888

  Injection, epoetin beta, 1 microgram, (for non esrd use)

• J0889

  Daprodustat, oral, 1 mg, (for esrd on dialysis)

• J0890

  Injection, peginesatide, 0.1 mg (for esrd on dialysis)

• J0891

  Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/21/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.